2025-04-012026-03-312026-03-31falseSC380729SCOTNURSING & MEDICAL SERVICES LIMITED2026-05-21falseiso4217:GBPxbrli:pureSC3807292025-03-31SC3807292026-03-31SC3807292025-04-012026-03-31SC3807292024-03-31SC3807292025-03-31SC3807292024-04-012025-03-31SC380729bus:SmallEntities2025-04-012026-03-31SC380729bus:AuditExempt-NoAccountantsReport2025-04-012026-03-31SC380729bus:FullAccounts2025-04-012026-03-31SC380729bus:PrivateLimitedCompanyLtd2025-04-012026-03-31SC380729core:WithinOneYear2026-03-31SC380729core:AfterOneYear2026-03-31SC380729core:WithinOneYear2025-03-31SC380729core:AfterOneYear2025-03-31SC380729core:ShareCapital2026-03-31SC380729core:SharePremium2026-03-31SC380729core:RevaluationReserve2026-03-31SC380729core:OtherReservesSubtotal2026-03-31SC380729core:RetainedEarningsAccumulatedLosses2026-03-31SC380729core:ShareCapital2025-03-31SC380729core:SharePremium2025-03-31SC380729core:RevaluationReserve2025-03-31SC380729core:OtherReservesSubtotal2025-03-31SC380729core:RetainedEarningsAccumulatedLosses2025-03-31SC380729core:LandBuildings2026-03-31SC380729core:PlantMachinery2026-03-31SC380729core:Vehicles2026-03-31SC380729core:FurnitureFittings2026-03-31SC380729core:OfficeEquipment2026-03-31SC380729core:NetGoodwill2026-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2026-03-31SC380729core:ListedExchangeTraded2026-03-31SC380729core:UnlistedNon-exchangeTraded2026-03-31SC380729core:LandBuildings2025-03-31SC380729core:PlantMachinery2025-03-31SC380729core:Vehicles2025-03-31SC380729core:FurnitureFittings2025-03-31SC380729core:OfficeEquipment2025-03-31SC380729core:NetGoodwill2025-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2025-03-31SC380729core:ListedExchangeTraded2025-03-31SC380729core:UnlistedNon-exchangeTraded2025-03-31SC380729core:LandBuildings2025-04-012026-03-31SC380729core:PlantMachinery2025-04-012026-03-31SC380729core:Vehicles2025-04-012026-03-31SC380729core:FurnitureFittings2025-04-012026-03-31SC380729core:OfficeEquipment2025-04-012026-03-31SC380729core:NetGoodwill2025-04-012026-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-31SC380729core:ListedExchangeTraded2025-04-012026-03-31SC380729core:UnlistedNon-exchangeTraded2025-04-012026-03-31SC380729core:MoreThanFiveYears2025-04-012026-03-31SC380729core:Non-currentFinancialInstruments2026-03-31SC380729core:Non-currentFinancialInstruments2025-03-31SC380729dpl:CostSales2025-04-012026-03-31SC380729dpl:DistributionCosts2025-04-012026-03-31SC380729core:LandBuildings2025-04-012026-03-31SC380729core:PlantMachinery2025-04-012026-03-31SC380729core:Vehicles2025-04-012026-03-31SC380729core:FurnitureFittings2025-04-012026-03-31SC380729core:OfficeEquipment2025-04-012026-03-31SC380729dpl:AdministrativeExpenses2025-04-012026-03-31SC380729core:NetGoodwill2025-04-012026-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-31SC380729dpl:GroupUndertakings2025-04-012026-03-31SC380729dpl:ParticipatingInterests2025-04-012026-03-31SC380729dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-31SC380729core:ListedExchangeTraded2025-04-012026-03-31SC380729dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-31SC380729core:UnlistedNon-exchangeTraded2025-04-012026-03-31SC380729dpl:CostSales2024-04-012025-03-31SC380729dpl:DistributionCosts2024-04-012025-03-31SC380729core:LandBuildings2024-04-012025-03-31SC380729core:PlantMachinery2024-04-012025-03-31SC380729core:Vehicles2024-04-012025-03-31SC380729core:FurnitureFittings2024-04-012025-03-31SC380729core:OfficeEquipment2024-04-012025-03-31SC380729dpl:AdministrativeExpenses2024-04-012025-03-31SC380729core:NetGoodwill2024-04-012025-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-31SC380729dpl:GroupUndertakings2024-04-012025-03-31SC380729dpl:ParticipatingInterests2024-04-012025-03-31SC380729dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-31SC380729core:ListedExchangeTraded2024-04-012025-03-31SC380729dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-31SC380729core:UnlistedNon-exchangeTraded2024-04-012025-03-31SC380729core:NetGoodwill2026-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2026-03-31SC380729core:LandBuildings2026-03-31SC380729core:PlantMachinery2026-03-31SC380729core:Vehicles2026-03-31SC380729core:FurnitureFittings2026-03-31SC380729core:OfficeEquipment2026-03-31SC380729core:AfterOneYear2026-03-31SC380729core:WithinOneYear2026-03-31SC380729core:ListedExchangeTraded2026-03-31SC380729core:UnlistedNon-exchangeTraded2026-03-31SC380729core:ShareCapital2026-03-31SC380729core:SharePremium2026-03-31SC380729core:RevaluationReserve2026-03-31SC380729core:OtherReservesSubtotal2026-03-31SC380729core:RetainedEarningsAccumulatedLosses2026-03-31SC380729core:NetGoodwill2025-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2025-03-31SC380729core:LandBuildings2025-03-31SC380729core:PlantMachinery2025-03-31SC380729core:Vehicles2025-03-31SC380729core:FurnitureFittings2025-03-31SC380729core:OfficeEquipment2025-03-31SC380729core:AfterOneYear2025-03-31SC380729core:WithinOneYear2025-03-31SC380729core:ListedExchangeTraded2025-03-31SC380729core:UnlistedNon-exchangeTraded2025-03-31SC380729core:ShareCapital2025-03-31SC380729core:SharePremium2025-03-31SC380729core:RevaluationReserve2025-03-31SC380729core:OtherReservesSubtotal2025-03-31SC380729core:RetainedEarningsAccumulatedLosses2025-03-31SC380729core:NetGoodwill2024-03-31SC380729core:IntangibleAssetsOtherThanGoodwill2024-03-31SC380729core:LandBuildings2024-03-31SC380729core:PlantMachinery2024-03-31SC380729core:Vehicles2024-03-31SC380729core:FurnitureFittings2024-03-31SC380729core:OfficeEquipment2024-03-31SC380729core:AfterOneYear2024-03-31SC380729core:WithinOneYear2024-03-31SC380729core:ListedExchangeTraded2024-03-31SC380729core:UnlistedNon-exchangeTraded2024-03-31SC380729core:ShareCapital2024-03-31SC380729core:SharePremium2024-03-31SC380729core:RevaluationReserve2024-03-31SC380729core:OtherReservesSubtotal2024-03-31SC380729core:RetainedEarningsAccumulatedLosses2024-03-31SC380729core:AfterOneYear2025-04-012026-03-31SC380729core:WithinOneYear2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-31SC380729core:Non-currentFinancialInstrumentscore:CostValuation2026-03-31SC380729core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-31SC380729core:Non-currentFinancialInstrumentscore:CostValuation2025-03-31SC380729core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-31SC380729core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-31SC380729bus:Director12025-04-012026-03-31SC380729bus:Director22025-04-012026-03-31SC380729bus:Director32025-04-012026-03-31SC380729core:FurnitureFittingsToolsEquipment2025-03-31SC380729core:FurnitureFittingsToolsEquipment2025-04-012026-03-31SC380729core:FurnitureFittingsToolsEquipment2026-03-31

SCOTNURSING & MEDICAL SERVICES LIMITED

Registered Number
SC380729
(Scotland)

Unaudited Financial Statements for the Year ended
31 March 2026

SCOTNURSING & MEDICAL SERVICES LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

RUSHFORTH, Ann Bruce
RUSHFORTH, Douglas Alexander
SINCLAIR, Anne Logie

Registered Address

Wright Business Centre
1 Lonmay Road
Glasgow
G33 4EL

Registered Number

SC380729 (Scotland)
SCOTNURSING & MEDICAL SERVICES LIMITED
Statement of Financial Position
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets315,10314,105
15,10314,105
Current assets
Debtors4144,963118,951
Cash at bank and on hand120,463217,970
265,426336,921
Creditors amounts falling due within one year5(300,306)(439,715)
Net current assets (liabilities)(34,880)(102,794)
Total assets less current liabilities(19,777)(88,689)
Creditors amounts falling due after one year6-(6,068)
Provisions for liabilities(2,130)(1,518)
Net assets(21,907)(96,275)
Capital and reserves
Called up share capital100100
Profit and loss account(22,007)(96,375)
Shareholders' funds(21,907)(96,275)
The financial statements were approved and authorised for issue by the Board of Directors on 21 May 2026, and are signed on its behalf by:
SINCLAIR, Anne Logie
Director
Registered Company No. SC380729
SCOTNURSING & MEDICAL SERVICES LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.
Basis of preparation
The financial statements have been prepared under the historical cost convention on a going concern basis unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.
Going concern
The financial statements have been prepared on a going concern basis. The company has net liabilities at the balance sheet date. The company is thus dependent on the continued financial support of its creditors. The directors are confident of this continuing support and of the company's long term trading prospects. After due consideration on the potential impact of future commitments, the directors consider it appropriate to prepare the financial statements on a going concern basis.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Turnover policy
Turnover represents the invoiced value of services provided during the period. The company's policy is to recognise a sale when all the risks and rewards in connection with the services have been passed to the customer.
Deferred tax
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. The assets residual values, useful lives and depreciation methods are reviewed and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposal are determined by comparing the proceeds with the carrying amount and are recognised in the Income Statement Depreciation is provided on all tangible fixed assets as follows:

Straight line (years)
Plant and machinery3
Fixtures and fittings3
Vehicles5
Office Equipment3
Financial instruments
The company enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, and loans from banks.
Government grants or assistance
Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to the Income Statement at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in the Income Statement in the same period as the related expenditure.
2.Average number of employees

20262025
Average number of employees during the year6665
3.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 259,6689,7965,42124,76449,649
Additions---7,2647,264
At 31 March 269,6689,7965,42132,02856,913
Depreciation and impairment
At 01 April 259,2261,1433,27321,90235,544
Charge for year4421,9591,1102,7556,266
At 31 March 269,6683,1024,38324,65741,810
Net book value
At 31 March 26-6,6941,0387,37115,103
At 31 March 254428,6532,1482,86214,105
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables127,605115,489
Other debtors17,358858
Prepayments and accrued income-2,604
Total144,963118,951
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables4,41414,048
Bank borrowings and overdrafts6,56710,000
Taxation and social security95,04877,450
Redeemable preference shares, liability100,000100,000
Other creditors36,456120,984
Accrued liabilities and deferred income57,821117,233
Total300,306439,715
6.Creditors: amounts due after one year

2026

2025

££
Bank borrowings and overdrafts-6,068
Total-6,068
7.Related party transactions
Interest of £7,500 (2025: £81,144) has been accrued on preference shares owed to a director.